Добро пожаловать на наш сайт!
Welcome to our website!

Journal of Microbiology Research 2014, 4(1): 14-17 DOI: 10.5923/j.microbiology.20140401.03
phone + 998 98 126 74 06
skype fargals
email info@fargals.com
Journal of Microbiology Research 2014, 4(1): 14-17 DOI: 10.5923/j.microbiology.20140401.03
2014-04-01

F.G. Nazirov, R.A. Ibadov, Z.A. Shanieva, A.Sh. Arifjanov, A.D. Eshonhodjaev, T.B. Ugarova, N.A. Strijkov, P.G. Komirenko

ORIGINAL ANTI-MICROBIAL TREATMENT OF PURULENT-INFLAMMATORY LUNG DISEASES IN PATIENTS SUPPORTED BY LONG-TERM ARTIFICIAL VENTILATION OF LUNGS
Republican Specialized Center of Surgery named after ac.V.Vahidov. Tashkent, Uzbekistan

 Abstract We analysed the spectrum of microbial agents causing bronchial-    pulmonary complications in 58 patients who underwent various surgical        interventions and were supported by long-term artificial ventilation of lungs.      "FarGALS", a medication with high antimicrobial activity developed and produced  at  V.Vakhidov Republican Specialised Centre of Surgery, was used for the first time in  the nebuliser therapy. In comparison with other antimicrobial agents, the use of "FarGALS" has reduced complications of long-period artificial ventilation, justifying further investigations of this medication for the use in nebuliser therapy by intensive care units (ICU).